Goldstone Financial Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$348K Buy
960
+8
+0.8% +$2.74K 0.03% 201
2026
Q1
$335K Buy
952
+63
+7% +$22.5K 0.04% 189
2025
Q4
$291K Buy
889
+109
+14% +$34.6K 0.03% 194
2025
Q3
$220K Buy
780
+16
+2% +$4.64K 0.03% 209
2025
Q2
$228K Sell
764
-5
-0.7% -$1.42K 0.03% 192
2025
Q1
$239K Buy
+769
New +$227K 0.04% 181
2024
Q4
Sell
-785
Closed -$253K 201
2024
Q3
$253K Buy
+785
New +$257K 0.04% 165

Other funds holding AMGN

Goldstone Financial Group's AMGN Position: Q2 2026 in Review

Goldstone Financial Group increased its Amgen (AMGN) stake by 0.84% in Q2 2026, buying an estimated $2.74K and bringing the position to 960 shares worth $348K. The position accounts for 0.03% of the portfolio, ranked #201.

Goldstone Financial Group first reported a position in AMGN in Q3 2024 and has held it in 7 quarters since. 3,160 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Goldstone Financial Group held 960 shares of Amgen worth $348K as of Q2 2026.
  • Goldstone Financial Group bought 8 Amgen shares in Q2 2026, an estimated $2.74K.
  • Amgen made up 0.03% of Goldstone Financial Group's portfolio in Q2 2026, its #201 holding.
  • Goldstone Financial Group first reported a position in Amgen in Q3 2024 and has held it in 7 quarters since.
  • 3,160 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Goldstone Financial Group's 13F filing for Q2 2026, filed 11 Aug 2026.